These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20658629)

  • 1. Compound heterozygosity for two new TERT mutations in a patient with aplastic anemia.
    Aspesi A; Vallero S; Rocci A; Pavesi E; Lanciotti M; Ramenghi U; Dianzani I
    Pediatr Blood Cancer; 2010 Sep; 55(3):550-3. PubMed ID: 20658629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in dyskeratosis congenita.
    Nishio N; Kojima S
    Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase.
    Yang D; He Q; Kim H; Ma W; Songyang Z
    J Biol Chem; 2011 Jul; 286(26):23022-30. PubMed ID: 21536674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A spectrum of severe familial liver disorders associate with telomerase mutations.
    Calado RT; Regal JA; Kleiner DE; Schrump DS; Peterson NR; Pons V; Chanock SJ; Lansdorp PM; Young NS
    PLoS One; 2009 Nov; 4(11):e7926. PubMed ID: 19936245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita associated with leukoplakia of the tongue.
    Noto Z; Tomihara K; Furukawa K; Noguchi M
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
    Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
    Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
    N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
    Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
    Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations.
    Marrone A; Sokhal P; Walne A; Beswick R; Kirwan M; Killick S; Williams M; Marsh J; Vulliamy T; Dokal I
    Haematologica; 2007 Aug; 92(8):1013-20. PubMed ID: 17640862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the interpretation of a germline TERT variant in a patient with juvenile myelomonocytic leukemia.
    Janczar S; Kirschner M; Beier F; Brümmendorf TH; Ussowicz M; Babol-Pokora K; Oszer A; Yoshimi A; Kalwak K; Mlynarski W
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29909. PubMed ID: 35927969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.
    Arias-Salgado EG; Galvez E; Planas-Cerezales L; Pintado-Berninches L; Vallespin E; Martinez P; Carrillo J; Iarriccio L; Ruiz-Llobet A; Catalá A; Badell-Serra I; Gonzalez-Granado LI; Martín-Nalda A; Martínez-Gallo M; Galera-Miñarro A; Rodríguez-Vigil C; Bastos-Oreiro M; Perez de Nanclares G; Leiro-Fernández V; Uria ML; Diaz-Heredia C; Valenzuela C; Martín S; López-Muñiz B; Lapunzina P; Sevilla J; Molina-Molina M; Perona R; Sastre L
    Orphanet J Rare Dis; 2019 Apr; 14(1):82. PubMed ID: 30995915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow failure and the new telomere diseases: practice and research.
    Young NS
    Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita, stem cells and telomeres.
    Kirwan M; Dokal I
    Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic TERT variant leads to Hoyeraal-Hreidarsson syndrome with additional dyskeratosis congenita findings.
    Çepni E; Satkın NB; Moheb LA; Rocha ME; Kayserili H
    Am J Med Genet A; 2022 Apr; 188(4):1226-1232. PubMed ID: 34890115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of natural telomerase mutations found in patients with hematologic disorders.
    Xin ZT; Beauchamp AD; Calado RT; Bradford JW; Regal JA; Shenoy A; Liang Y; Lansdorp PM; Young NS; Ly H
    Blood; 2007 Jan; 109(2):524-32. PubMed ID: 16990594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.
    Marrone A; Walne A; Tamary H; Masunari Y; Kirwan M; Beswick R; Vulliamy T; Dokal I
    Blood; 2007 Dec; 110(13):4198-205. PubMed ID: 17785587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
    Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
    Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.